Barinthus Biotherapeutics plc
BRNS
$0.839
$0.0161.94%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 4.30% | -9.91% | -9.38% | -8.53% | -11.36% |
Total Receivables | -66.04% | 271.06% | -11.36% | -19.49% | 34.76% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -17.06% | -9.59% | 53.41% | -5.72% | 19.78% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 348.71% | -25.88% | -62.63% | 13.64% | 315.21% |
Total Current Assets | -6.62% | 2.10% | -7.86% | -8.78% | -8.28% |
|
|||||
Total Current Assets | -6.62% | 2.10% | -7.86% | -8.78% | -8.28% |
Net Property, Plant & Equipment | -35.27% | -0.47% | -3.65% | -2.38% | -1.73% |
Long-term Investments | -- | 0.00% | 0.00% | 0.00% | 0.00% |
Goodwill | -- | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Intangibles | -3.47% | -3.36% | -3.25% | -3.15% | -3.05% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -4.86% | 4.51% | 0.11% | 0.34% | -16.40% |
Total Assets | -15.03% | 1.04% | -6.38% | -7.00% | -6.72% |
|
|||||
Total Accounts Payable | -19.57% | 20.34% | 119.97% | -27.42% | -68.88% |
Total Accrued Expenses | 19.57% | -22.49% | 23.39% | -9.57% | -22.74% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -3.32% | 3.65% | 0.37% | 6.95% | 18.92% |
Total Finance Division Other Current Liabilities | -14.97% | 143.62% | -41.49% | -- | -- |
Total Other Current Liabilities | -14.97% | 143.62% | -41.49% | -- | -- |
Total Current Liabilities | 3.88% | -3.32% | 21.46% | 1.88% | -32.16% |
|
|||||
Total Current Liabilities | 3.88% | -3.32% | 21.46% | 1.88% | -32.16% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -5.58% | 0.27% | -2.23% | -2.63% | -0.10% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 28.07% | -6.54% | -0.48% | 0.32% | -19.02% |
Total Liabilities | 3.30% | -2.44% | 9.08% | -0.16% | -19.95% |
|
|||||
Common Stock & APIC | 0.41% | 0.41% | 0.40% | 0.55% | 0.23% |
Retained Earnings | -9.46% | -3.88% | -8.81% | -8.77% | -10.86% |
Treasury Stock & Other | -66.71% | 37.25% | 0.66% | -6.80% | 25.10% |
Total Common Equity | -18.37% | 1.71% | -8.85% | -8.00% | -4.41% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -18.37% | 1.71% | -8.85% | -8.00% | -4.41% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -36.53% | -2.91% | -6.01% | -13.27% | 2.93% |
Total Equity | -18.39% | 1.70% | -8.85% | -8.01% | -4.40% |
|